Therapy of severe ischemic stroke: Breaking the conventional thinking

Cerebrovascular Diseases

Volumn 20, Issue SUPPL. 2, 2005, Pages 169-178

  Schwab, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain edema; Craniectomy; Hypothermia; Stroke

Indexed keywords

ADRENALIN; BARBITURIC ACID DERIVATIVE; CORTICOSTEROID; DOPAMINE; FUROSEMIDE; GLYCEROL; MANNITOL; OSMOTIC AGENT; THIOPENTAL; TROMETAMOL; GLUCOCORTICOID;

BLEEDING TENDENCY; BRAIN HERNIA; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN TEMPERATURE; BREATHING; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CIRCULATION; CONFERENCE PAPER; CRANIECTOMY; DECOMPRESSION SURGERY; DIARRHEA; DISEASE PREDISPOSITION; ELECTROLYTE DISTURBANCE; EMERGENCY WARD; GASTROINTESTINAL HEMORRHAGE; HEART ARREST; HEART MUSCLE INJURY; HEMOGLOBINURIA; HEMOLYSIS; HUMAN; HYPERGLYCEMIA; HYPOTENSION; HYPOTHERMIA; INDUCED HYPOTHERMIA; INFECTION; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE; LIVER DYSFUNCTION; MORTALITY; NAUSEA; NEUROPROTECTION; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SURGICAL TECHNIQUE; VOMITING; CRYOANESTHESIA; PATHOLOGY; REVIEW;

BARBITURATES; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; GLUCOCORTICOIDS; HUMANS; HYPOTHERMIA, INDUCED; INTRACRANIAL PRESSURE; PATIENT SELECTION; TROMETHAMINE;

EID: 33644793089     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089371     Document Type: Conference Paper

References (54)

1. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R: 'Malignant' middle cerebral artery territory infarction: Clinical course and prognostic signs. Arch Neurol 1996;53:309-315.
2. Berrouschot J, Sterker M, Bettin S, Koster J, Schneider D: Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care. Intensive Care Med 1998;24:620-623.
3. Schwab S, Aschoff A, Spranger M, Albert F, Hacke W: The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology 1996;47:393-398.
4. Schwab S, Rieke K, Aschoff A, Albert F, von Kummer R, Hacke W: Hemicraniectomy in space-occupying hemispheric infarction: useful intervention or desperate activism? Cerebrovasc Dis 1996;6:325-329.
5. Kaufmann AM, Cardoso ER: Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992;77:584-589.
6. Garcia-Sola R, Pulido P, Capilla P: The immediate and long-term effects of mannitol and glycerol. A comparative experimental study. Acta Neurochir (Wien) 1991;109:114-121.
7. Marshall LF, Smith RW, Rauscher LA, Shapiro HM: Mannitol dose requirements in brain-injured patients. J Neurosurg 1978;48:169-172.
8. James HE: Methodology for the control of intracranial pressure with hypertonic mannitol. Acta Neurochir (Wien) 1980;51:161-172.
9. McGraw CP, Howard G: Effect of mannitol on increased intracranial pressure. Neurosurgery 1983;13:269-271.
10. Muizelaar JP, Lutz HA 3rd, Becker DP: Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg 1984;61:700-706.
11. Mendelow AD, Teasdale GM, Russell T, Flood J, Patterson J, Murray GD: Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg 1985;63:43-48.
12. Kirkpatrick PJ, Smielewski P, Piechnik S, Pickard JD, Czosnyka M: Early effects of mannitol in patients with head injuries assessed using bedside multimodality monitoring. Neurosurgery 1996;39:714-720.
13. Pollay M, Fullenwider C, Roberts PA, Stevens FA: Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983;59:945-950.
14. Node Y, Nakazawa S: Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon. Adv Neurol 1990;52:359-363.
15. Bereczki D, Liu M, do Prado GF, Fekete I: Mannitol for acute stroke. Cochrane Database Syst Rev 2001;(1):CD001153.
16. Hartl R, Ghajar J, Hochleuthner H, et al: Hypertonic/hyperoncotic saline reliably reduces ICP in severely head-injured patients with intracranial hypertension. Acta Neurochir Suppl (Wien) 1997;70:126-129.
17. Khanna S, Davis D, Peterson B, Fisher B, Tung H, O'Quigley J, Deutsch R: Use of hypertonic saline in the treatment of severe refractory posttraumatic intracranial hypertension in pediatric traumatic brain injury. Crit Care Med 2000;28:1144-1151.
18. Gemma M, Cozzi S, Tommasino C, et al: 7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol 1997;9:329-334.
19. Schwarz S, Schwab S, Bertram M, et al: Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998;29:1550-1555.
20. Gaab MR, Seegers K, Smedema RJ, Heissler HE, Goetz C: A comparative analysis of THAM (Tris-buffer) in traumatic brain oedema. Acta Neurochir Suppl (Wien) 1990;51:320-323.
21. Wolf AL, Levi L, Marmarou A, Ward JD, Muizelaar PJ, Choi S, Young H, Rigamonti D, Robinson WL: Effect of THAM upon outcome in severe head injury: A randomized prospective clinical trial. J Neurosurg 1993;78:54-59.
22. Olsen RW: GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem 1981;37:1-13.
23. Woodcock J, Ropper AH, Kennedy SK: High dose barbiturates in non-traumatic brain swelling: ICP reduction and effect on outcome. Stroke 1982;13:785-787.
24. Lee MW, Deppe SA, Sipperly ME, Barrette RR, Thompson DR: The efficacy of barbiturate coma in the management of uncontrolled intracranial hypertension following neurosurgical trauma. J Neurotrauma 1994;11:325-331.
25. Schwab S, Spranger M, Schwarz S, Hacke W: Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology 1997;48:1608-1613.
26. Cormio M, Gopinath SP, Valadka A, Robertson CS: Cerebral hemodynamic effects of pentobarbital coma in head-injured patients. J Neurotrauma 1999;16:927-936.
27. Schwartz ML, Tator CH, Rowed DW, Reid SR, Meguro K, Andrews DF: The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 1984;11:434-440.
28. Qizilbach N, Lewington SL, Lopez-Arrieta JM: Corticosteroids for acute ischemic stroke (Cochrane Review). The Cochrane Library, Issue 4, 2001.
29. Poungvarin N, Bhoopat W, Viriyavejakul A, Rodprasert P, Buranasiri P, Sukondhabhant S, Hensley MJ, Strom BL: Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 1987;316:1229-1233.
30. Kondziolka D, Fazl M: Functional recovery after decompressive craniectomy for cerebral infarction. Neurosurgery 1988;23:143-147.
31. Delashaw JB, Broaddus WC, Kassell NF, Haley EC, Pendleton GA, Vollmer DG, Maggio WW, Grady MS: Treatment of right hemispheric cerebral infarction by hemicraniectomy. Stroke 1990;21:874-881.
32. Jourdan C, Convert J, Mottolese C, Bachour E, Gharbi S, Artru F: Evaluation of the clinical benefit of decompression hemicraniectomy in intracranial hypertension not controlled by medical treatment. Neurochirurgie 1993;39:304-310.
33. Kalia KK, Yonas H: An aggressive approach to massive middle cerebral artery infarction. Arch Neurol 1993;50:1293-1297.
34. Carter BS, Ogilvy CS, Candia GJ, Rosas HD, Buonanno F: One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery 1997;40:1168-1175.
35. Schwab S, Steiner T, Aschoff A, Schwarz S, Steiner HH, Jansen O, Hacke W: Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998;29:1888-1893.
36. Holtkamp M, Buchheim K, Unterberg A, Hoffmann O, Schielke E, Weber JR, Masuhr F: Hemicraniectomy in elderly patients with space occupying media infarction: improved survival but poor functional outcome. J Neurol Neurosurg Psychiatry 2001;70:226-228.
37. Mori K, Aoki A, Yamamoto T, Maeda M: Aggressive decompressive surgery in patients with massive hemispheric embolic cerebral infarction associated with severe brain swelling. Acta Neurochir (Wien) 2001;143:483-492.
38. Gupta R, Connolly ES, Mayer S, Elkind MS: Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke 2004;35:539-543.
39. Hofmeijer J, van der Worp HB, Amelink GJ, Algra A, Kappelle LJ: Decompressive surgery in space-occupying hemispheric infarction, a randomised controlled trial (abstract). Cerebrovasc Dis 2001;11(suppl 4):34.
40. Ginsberg MD: Adventures in the pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection: the 2002 Thomas Willis Lecture. Stroke 2003;34:214-223.
41. Maier CM, Ahern K, Cheng ML, Lee JE, Yenari MA, Steinberg GK: Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: effects on neurologic outcome, infarct size, apoptosis, and inflammation. Stroke 1998;29:2171-2180.
42. Corbett D, Thornhill J: Temperature modulation (hypothermic and hyperthermic conditions) and its influence on histological and behavioral outcomes following cerebral ischemia. Brain Pathol 2000;10:145-152.
43. Hajat C, Hajat S, Sharma P: Effects of post-stroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000;31:410-414.
44. Schwab S, Schwarz S, Aschoff A, Keller E, Hacke W: Moderate hypothermia and brain temperature in patients with severe middle cerebral artery infarction. Acta Neurochir Suppl (Wien) 1998;71:131-134.
45. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W: Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke 1998;29:2461-2466.
46. Kammersgaard LP, Rasmussen BH, Jorgensen HS, Reith J, Weber U, Olsen TS: Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: a case-control study: the Copenhagen Stroke Study. Stroke 2000;31:2251-2256.
47. Rajek A, Greif R, Sessler DI, Baumgardner J, Laciny S, Bastanmehr H: Core cooling by central venous infusion of ice-cold (4 degrees C and 20 degrees C) fluid: isolation of core and peripheral thermal compartments. Anesthesiology 2000;93:629-637.
48. Bernard SA, Buist MD, Monteiro O, Smith K: Induced hypothermia using large volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital cardiac arrest: a preliminary report. Resuscitation 2003;56:9-13.
49. Georgiadis D, Schwarz S, Kollmar R, Schwab S: Endovascular cooling for moderate hypothermia in patients with acute stroke: first results of a novel approach. Stroke 2001;32:2550-2553.
50. Schwab S, Georgiadis D, Berrouschot J, Schellinger PD, Graffangino C, Mayer SA: Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 2001;32:2033-2035.
51. Krieger DW, De Georgia MA, Abou-Chebl A, Andrefsky JC, Sila CA, Katzan IL, Mayberg MR, Furlan AJ: Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke 2001;32:1847-1854.
52. Krieger DW, De Georgia MA, Devlin T, Jauss M, Rordorf G, Koroshetz WJ, Davis S: Cooling acute ischemic brain damage (COOL AID): a randomized pilot trial of endovascular cooling for patients with acute ischemic stroke (abstract). Stroke 2001;34:248.
53. Schmutzhard E, Engelhardt K, Beer R, Brossner G, Pfausler B, Spiss H, Unterberger I, Kampfl A: Safety and efficacy of a novel intravascular cooling device to control body temperature in neurologic intensive care patients: a prospective pilot study. Crit Care Med 2002;30:2481-2488.
54. Tokutomi T, Morimoto K, Miyagi T, Yamaguchi S, Ishikawa K, Shigemori M: Optimal temperature for the management of severe traumatic brain injury: effect of hypothermia on intracranial pressure, systemic and intracranial hemodynamics, and metabolism. Neurosurgery 2003;52:102-112.